Hints and tips:
...The ruling was a significant win for the pharmaceutical companies GSK, Pfizer, Sanofi and Boehringer Ingelheim....
...Luke Hildyard, director of the High Pay Centre, a London-based think-tank. said chief executives at top Wall Street banks like JPMorgan, Goldman Sachs, Morgan Stanley and Bank of America still earned more...
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
..., Lewis & Bockius Innovation in people & skills Latham & Watkins In-house legal teams Most Innovative in-house legal team in North America Pfizer Innovation in strategic & risk advice Pfizer Innovation...
...Speaking at the Morgan Stanley Global Healthcare Conference on Tuesday, D’Amelio added that the putative timeline assumed “all of the data is positive”....
...the trading day were intense, with gauges of volatility surging to the highest levels since since October 2020, ahead of the US election and results of the effectiveness of vaccines being developed by Pfizer...
...Pfizer, AbbVie and Bristol-Myers Squibb all have blockbuster drugs due to lose exclusivity soon and have recently sealed multibillion-dollar deals....
...The AU will pay $6.75 a dose for the BioNTech/Pfizer vaccine and $10 for Johnson & Johnson’s, a single-dose product....
...The vaccine could fetch nearly $13bn in global sales next year, which would be evenly split between Pfizer and BioNTech, says Morgan Stanley....
...The aborted trials include Pfizer and Johnson & Johnson’s scrapped study in 2012 and Merck’s failed trial in 2017....
...After such strong reads from the first two releases (three if we count Russia’s Sputnik V), the disappointing AZN figures were perhaps bound to prompt downward pressure on the company’s shares....
...In August, Russia became the first country to approve a Covid-19 vaccine — named Sputnik V — for civilian use, but western experts cast doubt on its efficacy and safety....
...company’s stock fell 5.9 per cent to £76.78 on Monday as investors digested the deal; Goldman Sachs — the press release announcing the deal doled out financial advisory credit to its Wall Street neighbours Morgan...
...If there is a sense from this earnings season that confidence in a V-shaped recovery for profits is misplaced, then the impact will probably be hardest on companies with weak balance sheets, and on those...
...Jeffrey Kindler, former chairman and CEO of Pfizer, has joined Blackstone as a senior adviser. EQT Partners named Olof Svensson as its new head of shareholder relations....
...Analysts at Morgan Stanley expect more price rises in the coming weeks because Amgen, Merck and Novartis have yet to announce their new prices....
...“I would say that, as a team, we've pretty well discounted a uniform V-shaped recovery. The question is, is it U-shaped, is it W-shaped or parts of it L-shaped?”...
...Analysts from Morgan Stanley estimate that Moderna’s vaccine has a 65 per cent chance of success....
...Deutsche Bank’s satellite-powered shipping tracker indicates that Chinese economic activity has now stopped contracting, and some economists are predicting a V-shaped recovery....
...Earlier data increases our economists conviction in a V-shaped recovery: Economic data in aggregate have continued to surprise to the upside, building our confidence in a V-shaped recovery....
...On the last Sunday of April 2019, a sleek Gulfstream V jet belonging to Occidental Petroleum touched down at Omaha airport....
...Xerox wants to give HP’s board its walking papers We’re all guilty of overusing the David v Goliath trope but in the case of Xerox and HP, it really does apply....
...A planned takeover of Allergan by US drugmaker Pfizer in 2015 fell through a year later when Barack Obama’s administration took steps to scupper a deal which was designed to help Pfizer escape paying US...
...That an mRNA approach (also favoured by Pfizer and BioNTech) can produce antibodies is a decent proof of concept that the accelerated development pathway might, just might, work....
...Morgan Stanley and its Japanese partner MUFG have committed $38bn to finance the transaction, in one of the biggest bridge loans on record....
International Edition